NCT05804188 CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
| NCT ID | NCT05804188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thomas Riva |
| Condition | Intubation Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 105,000 participants |
| Start Date | 2024-01-08 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 105,000 participants in total. It began in 2024-01-08 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators' overall objective is to assess the incidence of critical events related to tracheal intubation at all international study sites. Furthermore, the study will investigate the used intubation techniques and identify possible improvement measures to increase patient safety.
Eligibility Criteria
Inclusion Criteria: * All paediatric patients requiring tracheal intubation, performed by the anaesthesia team for procedures or interventions requiring general anaesthesia * Patients from 0 - 16 years of age. * Informed or general consent given, according to the relevant ethics committee statement. Exclusion Criteria: * Refusal to give consent or withdrawal of consent if such is required by the relevant ethics committee. * Patients \>16 years
Contact & Investigator
Robert Greif, MD, Prof
STUDY CHAIR
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University
Frequently Asked Questions
Who can join the NCT05804188 clinical trial?
This trial is open to participants of all sexes, up to 16 Years, studying Intubation Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05804188 currently recruiting?
Yes, NCT05804188 is actively recruiting participants. Contact the research team at thomas.riva@insel.ch for enrollment information.
Where is the NCT05804188 trial being conducted?
This trial is being conducted at Boston, United States, Philadelphia, United States, Perth, Australia, Toronto, Canada and 4 additional locations.
Who is sponsoring the NCT05804188 clinical trial?
NCT05804188 is sponsored by Thomas Riva. The principal investigator is Robert Greif, MD, Prof at Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University. The trial plans to enroll 105,000 participants.